Brief: Sinomab Bioscience Posts Loss For Year RMB288.2 Mln Vs RMB122.6 Mln
21/03/2022 15:13
March 21 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* LOSS FOR YEAR RMB288.2 MILLION VERSUS RMB122.6 MILLION
Source text for Eikon: ID:nHKS9Wg6Xh
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience